Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The essential fatty acid (EFA) metabolic pathway is a series of biochemical processes by which essential fatty acids—primarily linoleic acid (LA, an omega-6 fatty acid) and alpha-linolenic acid (ALA, an omega-3 fatty acid)—are metabolized in the body into longer-chain polyunsaturated fatty acids and their bioactive derivatives. These EFAs are termed "essential" because humans cannot synthesize them de novo and must obtain them from dietary sources. The pathway involves desaturation and elongation reactions, ultimately leading to the production of eicosanoids, resolvins, and other mediators that play crucial roles in inflammation, cell signaling, and gene expression. Altered EFA metabolism is implicated in various diseases including cardiovascular disease, neurological disorders, and cancer.
Drugs targeting enzymes within the pathway (e.g., COX inhibitors) modulate the production of bioactive lipids (e.g., prostaglandins, thromboxanes). Statins can indirectly affect the pathway by influencing lipid metabolism and HMG-CoA reductase activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Essential Fatty Acid Metabolic Pathway (EFA Pathway).